Find your path to Sven
422 people in our graph share verified history with Sven β schools, employers, funds. One of them is your warm intro.
About
Sven Kili is a Partner at Saisei Ventures and a pharmaceutical physician with clinical experience in surgical and medical disciplines. He serves as a Translational Research grant committee member at the British Heart Foundation, a Board Member and Interim CMO and COO at Xintela AB, a Board Member and Investment Committee member at CCRM, Chair of the BIA Cell & Gene Advisory Committee, and an Executive Board Member of the Standards Coordinating Body. His areas of work include cell and gene therapies, clinical development, medical affairs, regulatory strategy for medicines and ATMP products, and market access planning.
ContactΒ· self-published, not guessed
Experience
- British Heart FoundationTranslational Research grant committee membercurrent2025 β present
- Saisei VenturesPartnercurrent2025 β present
- Saisei VenturesInvestment Advisor2023 β 2025
- Innovation Hubs for Gene TherapiesSteering Committee Chairmancurrent2021 β present
- SVEN KILI CONSULTING LTDPrincipalcurrent2018 β present
- UCLSteering Committee Chaircurrent2019 β presentLondon Area, United Kingdom
- BioIndustry AssociationChair - Cell & Gene Therapy Advisory Committeecurrent2016 β presentLondon Area, United Kingdom
- CCRMChief Development Officer2024 β 2025
- CCRMMember of the Board2017 β 2024Greater Toronto Area, Canada
- LGC GroupMember of The Scientific Advisory Board2019 β 2025London Area, United Kingdom
- Antion Biosciences SAChief Executive Officer2020 β 2023
- Xintela ABMember of the Board2014 β 2022Kalmar County, Sweden
- Standards Coordinating Body (SCB)Member of Executive Board2016 β 2020Washington DC-Baltimore Area
- GSKVP and Head of Cell & Gene Therapy Development2015 β 2018London Area, United Kingdom
- Genzyme BiosurgerySenior Director, Global Medical Affairs - Cell Therapy & Regenerative Medicine2011 β 2015UK & Boston
- Genzyme TherapeuticsSenior Associate Medical Director - Renal, CV and Biosurgery2011
- Genzyme BiosurgeryMedical Director - MACI2009 β 2010
- Genzyme BiosurgeryAssociate Medical Director2008 β 2009
- Geistlich BiomaterialsSenior Medical Advisor2004 β 2008
- NHSTrauma & Orthopaedics Specialist Registrar2000 β 2004
- NHSBasic Surgical Trainee1997 β 1999
- Don Fosters Dive, CaymanDive Instructor & Boat Captain1987 β 1989
- South African Defense ForceSignals and Encryption Officer1985 β 1986
Skills & more
+10 more
OrthopedicMedical AffairsUrologyHospitalsMedicineHealthcareClinical DevelopmentRegulatory SubmissionsFDAClinicalFrom Sven's professional profile.
Colleagues at Saisei Ventures
Frequently asked questions
- Who is Sven Kili?
- Sven Kili is a Partner at Saisei Ventures and a pharmaceutical physician with clinical experience in surgical and medical disciplines. He serves as a Translational Research grant committee member at the British Heart Foundation, a Board Member and Interim CMO and COO at Xintela AB, a Board Member and Investment Committee member at CCRM, Chair of the BIA Cell & Gene Advisory Committee, and an Executive Board Member of the Standards Coordinating Body. His areas of work include cell and gene therapies, clinical development, medical affairs, regulatory strategy for medicines and ATMP products, and market access planning.
- Where does Sven Kili work?
- Sven Kili is Partner at Saisei Ventures.
- Where did Sven Kili go to school?
- Sven Kili studied at Royal College of Surgeons of England (MRCS, Surgery); Stellenbosch University (MB ChB, Medicine & Surgery).
Same school
Also attended Stellenbosch University123
+ 117 more
Shared employers
Also worked at Xintela AB1
Also worked at GSK275
+ 269 more
Also worked at Genzyme Biosurgery243
+ 237 more































)


